Costs of medical care after open or minimally invasive prostate cancer surgery: A population-based analysis

Cancer

Volumn 118, Issue 12, 2012, Pages 3079-3086

  Lowrance, William T ^a,b   Eastham, James A ^b   Yee, David S ^b   Laudone, Vincent P ^b   Denton, Brian ^c   Scardino, Peter T ^b   Elkin, Elena B ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Sidney Kimmel Center for Prostate and Urologic Cancers   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Laparoscopy; Minimally invasive surgical procedures; Prostate; Prostatectomy; Prostatic neoplasms

Indexed keywords

ANTIANDROGEN; ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; PROSTATE SPECIFIC ANTIGEN;

ADVANCED CANCER; AFRICAN AMERICAN; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CAUCASIAN; CHARLSON COMORBIDITY SCORE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DRUG COST; GEOGRAPHY; GLEASON SCORE; HEALTH CARE COST; HEALTH SERVICE; HOME CARE; HOSPICE CARE; HOSPITAL CARE; HUMAN; INCOME; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICAL INSTRUMENTATION; MEDICARE; MINIMALLY INVASIVE RADICAL PROSTATECTOMY; MINIMALLY INVASIVE SURGERY; OPEN RADICAL PROSTATECTOMY; OUTPATIENT CARE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RACE; SCORING SYSTEM;

AGED; AGED, 80 AND OVER; HEALTH CARE COSTS; HUMANS; MALE; MEDICARE; PROSTATECTOMY; PROSTATIC NEOPLASMS; ROBOTICS; UNITED STATES;

EID: 84861904833     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26609     Document Type: Article

References (32)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
2. Intuitive Surgical, Inc. Annual Report 2009. Available at: https://materials.proxyvote.com/Approved/46120E/20100222/AR-53320/images/ Intuitive-Surgical-AR2009.pdf. Accessed date 00, 2011.
3. Hu JC, Gu X, Lipsitz SR, et al. Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA. 2009;302:1557-1564.
4. Lowrance WT, Elkin EB, Jacks LM, et al. Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes. J Urol. 2010;183:1366-1372.
5. Ficarra V, Novara G, Artibani W, et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol. 2009;55:1037-1063.
6. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011;103:117-128.
7. Gardner TA, Bissonette EA, Petroni GR, McClain R, Sokoloff MH, Theodorescu D. Surgical and postoperative factors affecting length of hospital stay after radical prostatectomy. Cancer. 2000;89:424-430. (Pubitemid 30489893)
8. Barbash GI, Glied SA. New technology and health care costs - the case of robot-assisted surgery. N Engl J Med. 2010;363:701-704.
9. Bolenz C, Gupta A, Hotze T, et al. Cost comparison of robotic, laparoscopic, and open radical prostatectomy for prostate cancer. Eur Urol. 2010;57:453-458.
10. Lotan Y, Cadeddu JA, Gettman MT. The new economics of radical prostatectomy: cost comparison of open, laparoscopic and robot assisted techniques. J Urol. 2004;172(4 pt 1):1431-1435. (Pubitemid 39249737)
11. Mouraviev V, Nosnik I, Sun L, et al. Financial comparative analysis of minimally invasive surgery to open surgery for localized prostate cancer: a single-institution experience. Urology. 2007;69:311-314. (Pubitemid 46274941)
12. Scales CD Jr, Jones PJ, Eisenstein EL, Preminger GM, Albala DM. Local cost structures and the economics of robot assisted radical prostatectomy. J Urol. 2005;174:2323-2329. (Pubitemid 41611814)
13. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(8 suppl):IV-3-IV-18.
14. Riley GF, Potosky AL, Lubitz JD, Kessler LG. Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care. 1995;33:828-841.
15. Warren JL, Brown ML, Fay MP, Schussler N, Potosky AL, Riley GF. Costs of treatment for elderly women with earlystage breast cancer in fee-for-service settings. J Clin Oncol. 2002;20:307-316. (Pubitemid 34032626)
16. Warren JL, Yabroff KR, Meekins A, Topor M, Lamont EB, Brown ML. Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst. 2008;100:888-897. (Pubitemid 351881955)
17. Burkhardt JH, Sunshine JH. Core-needle and surgical breast biopsy: comparison of three methods of assessing cost. Radiology. 1999;212:181-188. (Pubitemid 29302533)
18. Finkler SA. The distinction between cost and charges. Ann Intern Med. 1982;96:102-109.
19. The Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds. Table IV.A1.-Components of Historical and Projected Increases in HI Inpatient Hospital Payments. In: 2010 Annual Report of the Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds. Available at: https://www.cms.gov/ReportsTrustFunds/downloads/tr2010.pdf. Accessed December 29, 2010.
20. Centers for Medicare and Medicaid Services. Quarterly Index Levels in the CMS Medicare Economic Index using IHS Global Insight Inc. (IGI) Forecast Assumptions, by Expense Category: 1991-2020. Available at: http://www.cms.gov/ MedicareProgramRatesStats/downloads/mktbskt-economicindex.pdf. Accessed December 29, 2010.
21. Centers for Medicare and Medicaid Services. Wage Index Files. Table 4A. Available at: https://www.cms.gov/AcuteInpatientPPS/WIFN/itemdetail.asp? filterType=none&filterByDID=-99&sortByDID=3&sortOrder= ascending&itemID=CMS059968&intNumPerPage=10. Accessed December 29, 2010.
22. Centers for Medicare and Medicaid Services. Wage Index Files. Table 4B. Available at: https://www.cms.gov/AcuteInpatientPPS/WIFN/itemdetail.asp? filterType=none&filterByDID=-99&sortByDID=3&sortOrder= ascending&itemID=CMS059969&intNumPerPage=10. Accessed December 29, 2010.
23. Centers for Medicare and Medicaid Services. Addendum - 2006 Geographic Practice Cost Indicies by Medicare Carrier and Locality. Available at: https://www.cms.gov/Physician-FeeSched/PFSRVF/itemdetail.asp?filterType= none&filterByDID=-99&sortByDID=1&sortOrder=ascending&itemID= CMS1186375&intNumPerPage=10. Accessed December 29, 2010.
24. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383. (Pubitemid 17055592)
25. Klabunde CN, Warren JL, Legler JM. Assessing comorbidity using claims data: an overview. Med Care. 2002;40(8 suppl):IV-26-IV-35.
26. Institute of Medicine. Initial National Priorities for Comparative Effectiveness Research. Washington, DC: National Academies Press; 2009.
27. Lowrance WT, Tarin TV, Shariat SF. Evidence-based comparison of robotic and open radical prostatectomy. Scientific-WorldJournal. 2010;10:2228-2237.
28. Lotan Y, Bolenz C, Gupta A, et al. The effect of the approach to radical prostatectomy on the profitability of hospitals and surgeons. BJU Int. 2010;105:1531-1535.
29. Centers for Medicare and Medicaid Services. Medicare program; payment policies under the physician fee schedule and other revisions to Part B for CY 2010. Final rule with comment period. Fed Regist. 2009;74(226):61737-62188.
30. Intuitive Surgical. Investor Presentation Q2 2010. Available at: http://phx.corporate-ir.net/External.File?item= UGFyZW50SUQ9NTUyMDB8Q2hpbGRJRD0tMXxUeXBlPTM=&t=1. Accessed October 12, 2010.
31. Makarov DV, Yu JB, Desai RA, Penson DF, Gross CP. The association between diffusion of the surgical robot and radical prostatectomy rates. Med Care. 2011;49:333-339.
32. Nguyen PL, Gu X, Lipsitz SR, et al. Cost implications of the rapid adoption of newer technologies for treating prostate cancer. J Clin Oncol. 2011;29:1517-1524.